// App-Quantinova.ai

P2-02-05 : Circulating tumor cells in triple-negative and non-triple negative breast cancer patients show different genetic profiles

Researchers

Presenter

  • Bittner A-K

Principal Investigators

  • Hoffmann O

  • Hauch S

  • Kimmig R

  • Kasimir-Bauer S

Medical Centers

  • University Hospital of Essen, Essen, Germany

Locations

  • Germany

Companies

  • Qiagen Hannover GmbH

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • AKT Serine/Threonine Kinase 2

  • Anaplastic lymphoma Kinase

  • Neurogenic locus notch homolog protein 1

  • Breast cancer type 1 susceptibility protein

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Circulating tumor cells

  • Poly(ADP-Ribose) Polymerase 1

  • Cluster of differentiation 45

  • Cytokeratin 5

  • Epidermal growth factor receptor

  • Epithelial Cell Adhesion Molecule

  • erb-b2 receptor tyrosine kinase 2

  • Erb-B2 Receptor Tyrosine Kinase 3

  • Excision repair cross-complementation group 1

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved